Impact of a Long-Term Follow-Up Program on Adherence to Screening and Prevention Guidelines in Survivors of Allogeneic Bone Marrow Transplantation [0.03%]
allo-HSCT长期随访项目对其受者遵循筛查和预防指南的影响
Mariana Wanderley de Araujo,Maria Cecilia Montenegro Lijeron,Joaquim Gasparini Dos Santos et al.
Mariana Wanderley de Araujo et al.
Discontinuing Ciprofloxacin Prophylaxis in Allogeneic Stem Cell Transplantation Does Not Result in Inferior Outcomes [0.03%]
异基因干细胞移植中停止使用氟喹诺酮类预防性用药并未造成预后恶化
Krischan Braitsch,Vanessa Möbius,Katrin Koch et al.
Krischan Braitsch et al.
Background: The role of fluoroquinolone (FQ) prophylaxis during neutropenia after allogeneic stem cell transplantation (alloSCT) remains unclear due to concerns about antimicrobial resistance, microbiome disruption, and p...
Impact of prior CAR T-cell treatment on graft-vs-host disease and non-relapse mortality after allogeneic transplantation [0.03%]
既往CAR-T细胞治疗对异基因移植后移植物抗宿主病和非复发死亡的影响
Tamer Othman,Dongyun Yang,Geoffrey Shouse et al.
Tamer Othman et al.
Background: It remains unclear whether prior chimeric antigen receptor (CAR) T-cell therapy is associated with an increased risk of graft-versus-host disease (GVHD) or non-relapse mortality (NRM) following allogeneic hema...
FEASIBILITY AND INTERIM SAFETY AND EFFICACY ANALYSIS OF A FAST AUTOMATED PRODUCTION OF PROPHYLACTIC CMV-SPECIFIC CTLs AFTER ALLOGENEIC HSCT [0.03%]
异基因造血干细胞移植后快速自动化生产预防性CMV特异性CTL的可行性及期中安全性和有效性分析
Ma Aránzazu Bermúdez,Oscar M Pello,Miriam Sánchez-Escamilla et al.
Ma Aránzazu Bermúdez et al.
Background: Cytomegalovirus (CMV) infection remains a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Although letermovir prophylaxis has reduced CMV reactivation in serop...
Oral Sodium Butyrate Supplementation, Gut Microbiome Modulation, and Reduced Acute Graft-versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation [0.03%]
口服丁酸盐补充、肠道菌群调节和异基因造血干细胞移植后的急性移植物抗宿主病减少
Sukyung Kim,Hoonhee Seo,Sujin Jo et al.
Sukyung Kim et al.
Background: Acute graft-versus-host disease (aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Disruption of the gut microbiome during transplant...
Beyond Conventional CARs: Expanding the Targetable Antigen Landscape in CAR-T Cell Therapy [0.03%]
超越传统CAR：在CAR-T细胞治疗中拓展靶向抗原范围
Umida Yoziyeva,Alexey Yumashev,Shakhodat Kobilova et al.
Umida Yoziyeva et al.
Chimeric antigen receptor (CAR)-T cell therapy has emerged as a central pillar of immunotherapy, with astonishing achievements in the treatment of CD19-positive B cell malignancies and multiple myeloma. In recent years, substantial efforts ...
A Simplified Frailty Score Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation [0.03%]
简易衰弱评分可预测一线自体造血干细胞移植治疗多发性骨髓瘤患者的预后
Chelby Wakefield,Curtis Marcoux,Denái R Milton et al.
Chelby Wakefield et al.
Facilitation Of Related Donor Haematopoietic Stem Cell Donation By Unrelated Donor Registries: Recommendations From The World Marrow Donor Association [0.03%]
无关供者登记库促匹配造血干细胞捐献的有关建议——世界骨髓捐献协会制定
Meghann Cody,Heather E Stefanski,Eefke van Eerden et al.
Meghann Cody et al.